Italia - italiano - myHealthbox

guna - roe extract, bio-plex rna, oligoelementi, olio di jojoba, rhodiola rosea, ginseng, guaranÀ, oenothera biennis, coenzima q10 - crema - aqua, oenothera biennis oil, smithsonite extract, simmondsia chinensis oil, stearic acid, benzophenone-3, roe extract, saccharomyces/copper ferment, saccharomyces/iron ferment, saccharomyces/magnesium ferment, saccharomyces/silicon ferment, saccharomyces/z - cosmetici - creme

Italia - italiano - Ministero della Salute

princeps srl -

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

sifi s.p.a. - lacrime artificiali e altri preparati indifferenti - lacrime artificiali e altri preparati indifferenti

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

farmakopea s.p.a. - altri ipnotici e sedativi - altri ipnotici e sedativi

Unione Europea - italiano - EMA (European Medicines Agency)

viatris healthcare limited - imiquimod - condylomata acuminata; keratosis; keratosis, actinic; carcinoma, basal cell - antibiotici e chemioterapici per uso dermatologico - imiquimod cream is indicated for the topical treatment of :external genital and perianal warts (condylomata acuminata) in adults. small superficial basal cell carcinomas (sbccs) in adults. clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (aks) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - eltrombopag - porpora, trombocitopenica, idiopatica - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 e 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 e 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

bionorica se - altri urologici - altri urologici

Unione Europea - italiano - EMA (European Medicines Agency)

nanotherapeutics bohumil, s.r.o. - whole virion influenza vaccine, inactivated containing antigen of strain a/california/07/2009 (h1n1)v - disease outbreaks; influenza, human; immunization - vaccini - profilassi dell'influenza causata dal virus a (h1n1) v 2009. celvapan dovrebbe essere usato in conformità con le linee guida ufficiali.

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

teofarma s.r.l. - reserpine e diuretici, associazioni con altri farmaci - reserpine e diuretici, associazioni con altri farmaci

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformina cloridrato - diabete mellito, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.